H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis

[1] Sung H(2021)Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 71 209-249

[2] Ferlay J(2020)Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study Lancet Glob. Health 8 e1027-e1037

[3] Siegel RL(2018)Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Lancet (London, England) 391 1023-1075

[4] Laversanne M(2017)Breast cancer Lancet (London, England) 389 1134-1150

[5] Soerjomataram I(2021)Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology J. Natl. Compr. Cancer Netw.: JNCCN 19 77-102

[6] Jemal A(2017)Non-coding RNAs as drug targets Nat. Rev. Drug Discov. 16 167-179

[7] Heer E(2014)The noncoding RNA revolution-trashing old rules to forge new ones Cell 157 77-94

[8] Harper A(2013)RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts Nat. Rev. Mol. Cell Biol. 14 699-712

[9] Escandor N(2020)LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network Theranostics 10 10823-10837

[10] Sung H(2014)YB-1 protein: Functions and regulation Wiley Interdiscip. Rev. RNA 5 95-110

[1] Sung H(2021)Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 71 209-249

[2] Ferlay J(2020)Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study Lancet Glob. Health 8 e1027-e1037

[3] Siegel RL(2018)Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Lancet (London, England) 391 1023-1075

[4] Laversanne M(2017)Breast cancer Lancet (London, England) 389 1134-1150

[5] Soerjomataram I(2021)Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology J. Natl. Compr. Cancer Netw.: JNCCN 19 77-102

[6] Jemal A(2017)Non-coding RNAs as drug targets Nat. Rev. Drug Discov. 16 167-179

[7] Heer E(2014)The noncoding RNA revolution-trashing old rules to forge new ones Cell 157 77-94

[8] Harper A(2013)RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts Nat. Rev. Mol. Cell Biol. 14 699-712

[9] Escandor N(2020)LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network Theranostics 10 10823-10837

[10] Sung H(2014)YB-1 protein: Functions and regulation Wiley Interdiscip. Rev. RNA 5 95-110